向BRD4可以减轻乳腺母细胞瘤的干性和攻击性
Jiaxiang Xie1,2,3, Jingqi Zhang1,2,3, Gan Xiong1,2,3
1Hospital of Stomatology, Sun Yat-sen University, Guangzhou, China.
Oral diseases
|October 6, 2023
概括
odomain-4 (BRD4) 在乳腺母细胞瘤 (AM) 中被上调,导致瘤的进展和复发. 用BET抑制剂抑制BRD4为AM管理提供了一个有前途的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- odomain-4 (BRD4) 是odomain外终端 (BET) 蛋白家族的一员,与瘤进展有关.
- 对于BRD4在罕见的口腔瘤 - - 乳腺母细胞瘤 (AM) 中的作用尚不清楚.
研究的目的:
- 为了研究BRD4在乳腺母细胞瘤中的表达和功能意义.
- 评估在AM中准BRD4的治疗潜力.
主要方法:
- 免疫组织化学评估在AM组织中的BRD4表达.
- 试验室试验评估BRD4枯竭对AM细胞增殖,迁移和入侵的影响.
- RNA测序用于分析BRD4贫的AM细胞中的基因表达特征.
- 来自基因表达总汇 (GEO) 的AM表达数据的生物信息分析.
- 使用患者衍生AM器官的BET抑制剂 (BETi) 疗效的评估.
主要成果:
- 在传统的AM,复发性AM和乳腺癌中,BRD4表达显著上调.
- BRD4 枯竭抑制了AM细胞的增殖,入侵,迁移和瘤性.
- BET抑制剂降低了AM的攻击性,并抑制了患者衍生的AM有机体的生长.
- 生物信息分析表明BRD4通过Wnt和茎结相关途径促进AM的进展.
结论:
- BRD4通过调节Wnt和茎状性通路,促进了乳腺母细胞瘤的攻击性和复发.
- BRD4代表了改善乳腺母细胞瘤管理的潜在治疗标.
更多相关视频
07:03Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
Published on: October 2, 2020
4.6K
05:08Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
6.2K
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
